🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/04/1987 | 8,02 | 8,02 | 7,81 | 7,87 | -2,54% | 2,56% | 14.563.008 |
| 23/04/1987 | 8,11 | 8,15 | 8,01 | 8,07 | +0,16% | 1,72% | 10.884.528 |
| 22/04/1987 | 8,22 | 8,30 | 8,06 | 8,06 | -2,09% | 2,90% | 12.003.163 |
| 21/04/1987 | 8,03 | 8,23 | 7,99 | 8,23 | +1,97% | 2,97% | 13.019.933 |
| 20/04/1987 | 8,16 | 8,19 | 8,02 | 8,07 | -0,81% | 2,11% | 9.243.360 |
| 16/04/1987 | 8,31 | 8,32 | 8,12 | 8,14 | -1,60% | 2,47% | 18.430.128 |
| 15/04/1987 | 8,47 | 8,48 | 8,14 | 8,27 | -1,50% | 3,99% | 15.115.723 |
| 14/04/1987 | 8,46 | 8,47 | 8,24 | 8,40 | -1,02% | 2,66% | 14.730.898 |
| 13/04/1987 | 8,60 | 8,65 | 8,46 | 8,48 | -1,69% | 2,23% | 10.263.902 |
| 10/04/1987 | 8,48 | 8,64 | 8,47 | 8,63 | +0,77% | 2,03% | 13.168.958 |
| 09/04/1987 | 8,65 | 8,68 | 8,49 | 8,56 | -0,92% | 2,22% | 10.724.184 |
| 08/04/1987 | 8,56 | 8,67 | 8,51 | 8,64 | +1,87% | 1,78% | 11.116.555 |
| 07/04/1987 | 8,73 | 8,79 | 8,48 | 8,48 | -3,40% | 3,49% | 11.461.766 |
| 06/04/1987 | 8,70 | 8,79 | 8,65 | 8,78 | +2,24% | 1,52% | 10.486.498 |
| 03/04/1987 | 8,30 | 8,63 | 8,24 | 8,59 | +3,51% | 4,63% | 12.127.666 |
| 02/04/1987 | 8,29 | 8,35 | 8,29 | 8,30 | +0,32% | 0,72% | 6.919.315 |
| 01/04/1987 | 8,15 | 8,29 | 8,14 | 8,27 | +0,89% | 1,87% | 8.532.187 |
| 31/03/1987 | 8,16 | 8,24 | 8,14 | 8,20 | +1,06% | 1,30% | 9.671.573 |
| 30/03/1987 | 7,98 | 8,24 | 7,98 | 8,11 | -3,70% | 3,32% | 17.668.022 |
| 27/03/1987 | 8,68 | 8,68 | 8,40 | 8,42 | -2,46% | 3,21% | 9.792.302 |
| 26/03/1987 | 8,59 | 8,69 | 8,55 | 8,63 | +1,72% | 1,62% | 12.636.994 |
| 25/03/1987 | 8,62 | 8,62 | 8,49 | 8,49 | -1,69% | 1,54% | 9.233.928 |
| 24/03/1987 | 8,66 | 8,67 | 8,60 | 8,63 | -0,15% | 0,84% | 6.766.517 |
| 23/03/1987 | 8,67 | 8,69 | 8,59 | 8,65 | -0,38% | 1,15% | 10.131.854 |
| 20/03/1987 | 8,48 | 8,68 | 8,45 | 8,68 | +2,58% | 2,74% | 12.669.062 |
| 19/03/1987 | 8,34 | 8,46 | 8,34 | 8,46 | -0,47% | 1,51% | 6.936.293 |
| 18/03/1987 | 8,55 | 8,56 | 8,35 | 8,50 | +0,00% | 2,48% | 10.484.611 |
| 17/03/1987 | 8,23 | 8,51 | 8,20 | 8,50 | +3,30% | 3,78% | 8.881.171 |
| 16/03/1987 | 8,08 | 8,24 | 8,03 | 8,23 | +1,47% | 2,62% | 7.932.312 |
| 13/03/1987 | 8,34 | 8,35 | 8,06 | 8,11 | -2,31% | 3,49% | 11.593.814 |